Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders (NCT06112067) | Clinical Trial Compass
RecruitingNot Applicable
Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders
China18 participantsStarted 2023-10-16
Plain-language summary
This is a multi-center, single arm, prospective, open-label, extendable study for the efficacy and safety of combo-stim deep brain stimulation for treatment-refractory mental disorders (obsessive-compulsive disorder, schizophrenia, bipolar with depression, anorexia nervosa, gambling disorder and adult autism).
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.